Shorts

0:43
Why Rare Diseases Like EPP Are Frequently Misdiagnosed
2 months ago
by
Elizabeth Buzney, MD

1:00
Stop Calling Them Side Effects: Pro-Tips for Photodynamic Therapy
3 months ago
by
Neal Bhatia, MD

0:45
Why 86% of Patients Reported Feeling Better With This Hair Treatment
3 months ago
by
Maryanne Makredes Senna, MD

1:11
Celebrating National Sunscreen Day 2026
3 months ago
by
Whitney Hovenic, MD

0:39
When Should You Actually Use Patch Testing?
3 months ago
by
Patricia Delgado, DNP, AGPCNP, DCNP, PMHNP(+1 more)

0:59
The Sturge-Weber Foundation: Where Nobody Has to Hold Their Breath
3 months ago
by
Andrew C. Krakowski, MD(+2 more)

0:40
The Evolving Role of Biotech in Skin Care Manufacturing
3 months ago
by
Maxwell Stock

1:30
Dermatology News Update - May 21
3 months ago
by
Kaitlyn Bader, Assistant Managing Editor

0:37
Severe Pain With No Visible Signs: Erythropoietic Protoporphyria Insights
3 months ago
by
Elizabeth Buzney, MD

0:45
1.5x Better Hair Growth? Extended-Release Oral Minoxidil Explained
3 months ago
by
Maryanne Makredes Senna, MD

0:41
Could Improving Gut Health Also Improve Rosacea Symptoms?
3 months ago
by
Rajani Katta, MD(+1 more)

1:00
Red Light vs Blue Light for sBCC: What the Data Says
3 months ago
by
Todd Schlesinger, MD, FAAD, FASMS

1:00
Why Patients May Prefer PDT Over Surgery For sBCC
3 months ago
by
Neal Bhatia, MD

1:14
Don’t Be Rash: Fighting for Life-Changing HS Therapies in Pediatrics
3 months ago
by
Jillian Rork, MD(+1 more)

0:38
Don’t Be Rash: Why Standard Biologics Don’t Work for Patients with Down Syndrome
3 months ago
by
Jillian Rork, MD(+1 more)

0:30
Simplifying Infantile AD Care with Roflumilast Cream 0.05%
3 months ago
by
Patrick Burnett, MD, PhD

1:13
Why It's Not Too Late to Prevent Skin Cancer
3 months ago
by
Daniel Condie, MD

0:32
Understanding the Future of Dermatologic Drugs
3 months ago
by
Christopher G. Bunick, MD, PhD

0:44
Why New Options Like Nemolizumab are Needed in Pediatric AD
3 months ago
by
Lawrence Eichenfield, MD

1:00
Solving Systemic Side Effects in Cancer Treatment With PH762
3 months ago
by
Mary C. Spellman, MD

0:38
The Next Frontier: Bi- and Tri-Specifics for AD
3 months ago
by
Christopher G. Bunick, MD, PhD

1:00
The Connection Between Mental Health and Skin Conditions
3 months ago
by
Maria-Angeliki Gkini, MD, MSc, PhD

0:45
Dermatology as the Fast-Moving Frontier of Medicine
3 months ago
by
Brian Kim, MD, MTR, FAAD

1:30
Why Food Testing Often Fails for Atopic Dermatitis
3 months ago
by
Renata Block, DMSc, MMS, PA-C(+1 more)

1:30
Why Timing Is Everything With Oral Minoxidil for Pattern Hair Loss
3 months ago
by
Christopher G. Bunick, MD, PhD(+1 more)

1:30
Dermatology News Update - April 30
3 months ago
by
Kaitlyn Bader, Assistant Managing Editor

0:30
40% Complete Skin Clearance With Envudeucitinib
3 months ago
by
Andrew Blauvelt, MD, MBA

0:45
10-Minute Itch Relief for Infants With Atopic Dermatitis
4 months ago
by
Christopher G. Bunick, MD, PhD(+1 more)

0:41
Is It Atopic Dermatitis or Allergic Contact Dermatitis?
4 months ago
by
Jeff Yu, MD, MS
Advertisement
Advertisement
Trending on Dermatology Times
1
Envudeucitinib Achieves 54% PASI 100 Rate at 48 Weeks in Phase 3 Extension
2
Phase 3 STOP-HS Trials Highlight Promise of Oral JAK1 Inhibition for Moderate to Severe Disease
3
Biologic Therapies in AD and CSU: Progress and the Push for Precision Medicine
4
Sonelokimab Meets Primary End Point in Phase 3 Psoriatic Arthritis Trial
5


